What are the possible causes of leukopenia and thrombocytopenia, and can the SARS‑CoV‑2 spike protein induce them?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Causes of Low WBC and Low Platelets, and the Role of Spike Protein

Low white blood cells (leukopenia) and low platelets (thrombocytopenia) can result from numerous causes including bone marrow disorders, autoimmune conditions, medications, infections, and notably, SARS-CoV-2 infection—and yes, the spike protein itself can directly induce both conditions through multiple mechanisms.

Common Causes of Leukopenia and Thrombocytopenia

Hematologic Malignancies

  • Acute leukemias and myelodysplastic syndromes are primary causes of cytopenias due to bone marrow infiltration and impaired hematopoiesis 1
  • These conditions require urgent evaluation and treatment decisions based on prognostic scoring systems 1

Medications and Chemotherapy

  • Chemotherapy-induced myelosuppression is a well-established cause of both leukopenia and thrombocytopenia 1
  • Certain antiviral medications like remdesivir have documented hematological effects that warrant monitoring 1

Autoimmune Mechanisms

  • Autoantibodies or immune complexes can trigger destruction of both lymphocytes and platelets 2
  • This mechanism is particularly relevant in viral infections where immune dysregulation occurs 2

SARS-CoV-2 Spike Protein: Direct Hematologic Effects

Evidence for Spike Protein-Induced Thrombocytopenia

The SARS-CoV-2 spike protein can directly cause platelet activation, aggregation, and clearance, which explains thrombocytopenia observed in both COVID-19 infection and rare cases of vaccine-induced thrombotic thrombocytopenia (VITT) 3.

  • The spike protein's receptor-binding domain (RBD) binds directly to platelets via the αIIbβ3 integrin (partially through an RGD motif), causing platelet activation and subsequent clearance 3
  • This binding is exacerbated in Delta and Kappa variants, suggesting variant-specific differences in hematologic toxicity 3
  • Intravenous injection of recombinant RBD causes significant platelet clearance in animal models 3

Spike Protein Effects on White Blood Cells

The spike protein impacts both primitive hematopoietic stem cells and mature immune cells, contributing to leukopenia through multiple pathways 4:

  • Direct infection or exposure of hematopoietic stem/progenitor cells to spike protein causes functional impairment 4
  • Coronaviruses can infect bone marrow CD34+ cells via CD13 (aminopeptidase N) or CD66a (CEACAM1a) receptors, inducing growth inhibition and apoptosis 2
  • Lymphopenia is particularly prominent, with significant decreases in both CD4+ and CD8+ T lymphocyte subsets related to disease onset 2, 5

Complement-Mediated Mechanisms

The spike protein directly activates the alternative complement pathway, which contributes to both thrombocytopenia and endothelial damage 6:

  • Spike protein subunits 1 and 2 (but not N protein) activate complement, leading to C3 fragment and C5b-9 deposition on cells 6
  • This mechanism explains microangiopathy, thrombocytopenia, and thrombophilia observed in COVID-19 6
  • Factor D or C5 inhibition can block this complement-mediated damage 6

Clinical Implications and Frequency

COVID-19-Associated Cytopenias

  • Thrombocytopenia occurs in 5-41.7% of COVID-19 patients and correlates with worse outcomes 7, 8
  • Lymphopenia and thrombocytopenia are common hematological changes in SARS-CoV-2 infection, with lymphopenia being particularly characteristic 2, 8
  • Dynamic decreases in platelet counts are useful for prognosis 7

Mechanisms Summary

The spike protein causes cytopenias through:

  1. Direct platelet binding and activation via integrin receptors 3
  2. Infection of hematopoietic stem/progenitor cells via CD13 or CD66a 2
  3. Complement activation leading to cell destruction 6
  4. Autoimmune antibody formation triggered by viral infection 2
  5. Cytokine storm effects on bone marrow function 8

Important Clinical Caveats

Monitoring Recommendations

  • Screen for SARS-CoV-2 before initiating myelosuppressive chemotherapy in patients with hematologic malignancies 1
  • Avoid growth factors (G-CSF) in patients with moderate-to-severe COVID-19 due to risk of worsening inflammatory pulmonary injury 1, 9
  • Careful monitoring of coagulation markers and platelet counts is essential when considering anticoagulation in COVID-19 patients 1

Transfusion Thresholds

  • In resource-limited settings, consider non-prophylactic platelet transfusion strategies with thresholds <10,000/µL 1
  • Prophylactic antifibrinolytics (aminocaproic acid or tranexamic acid) may be considered in high bleeding-risk patients 1

Biomarkers of Severity

Elevated LDH, D-dimer, ferritin, and CRP often accompany severe COVID-19 cases with hematologic abnormalities and indicate poor prognosis 8.

References

2
Research

Hematological findings in SARS patients and possible mechanisms (review).

International journal of molecular medicine, 2004

Related Questions

Can COVID-19 present with leukopenia (low White Blood Cell (WBC) count)?
Are elevated SARS‑CoV‑2 spike protein antibody levels harmful?
What is the SARS‑CoV‑2 spike protein antibody and how is it measured to assess immunity after infection or vaccination?
What is considered a normal SARS‑CoV‑2 spike protein antibody level?
What is the diagnostic work‑up for preeclampsia in a pregnant woman after 20 weeks gestation and how should it be managed if diagnosed?
Why are eggs used as the carrier for technetium‑99m (Tc‑99m) in radiolabeled solid meals for gastric‑emptying studies?
How should Symbicort (budesonide/formoterol) be prescribed for COPD?
What serum β‑hCG level does a chemical pregnancy typically peak at, and when can a chemical pregnancy be safely ruled out given an extremely faint positive home pregnancy test six days ago with gradually darkening lines that have not yet matched the control line?
For a GHK‑Cu (copper‑complexed glycyl‑histidyl‑lysine) solution prepared at 1 mg/mL, how many insulin‑syringe units (1 unit = 0.01 mL) should be drawn for a specific dose?
Does a female patient with an obstructing kidney stone and hydronephrosis require flaxseed (flax) supplementation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.